SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 5, 2003
CRYOLIFE, INC.
(Exact name of registrant as specified in charter)
Commission File Number: 1-13165
Florida 59-2417093
(State or other jurisdiction of (IRS Employer Identification
incorporation) No.)
1655 Roberts Boulevard N.W.
Kennesaw, Georgia 30144
(Address of principal executive offices) (Zip Code)
Registrant's telephone number including area code: (770) 419-3355
(Former name or former address, if changed since last report)
Item 7. Financial Statements and Exhibits.
(a) Financial Statements.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibits.
Exhibit Number Description
-------------- -----------
99.1 Transcript of earnings conference call held August
5, 2003
Item 12. Results of Operations and Financial Condition
The information in this Form 8-K and the Exhibit attached hereto shall not be
deemed "filed" for purposes of Section 18 of the Securities Act of 1934, nor
shall it be deemed incorporated by reference in any filing under the Securities
Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly
set forth by specific reference in such filing.
On August 5, 2003, CryoLife, Inc. ("CryoLife") held its second quarter 2003
earnings conference call, broadcast live by webcast. A transcript of the call is
attached hereto as Exhibit 99.1 and incorporated by reference.
Except for the historical information contained in this report, the statements
made by CryoLife are forward-looking statements that involve risks and
uncertainties. All such statements are subject to the safe harbor created by the
Private Securities Litigation Reform Act of 1995. CryoLife's future financial
performance could differ significantly from the expectations of management and
from results expressed or implied in the earnings conference call. For further
information on other risk factors, please refer to the "Risk Factors" contained
in CryoLife's press release dated August 5, 2003, and in CryoLife's Form 10-K
for the fiscal year ended December 31, 2002, as filed with the Securities and
Exchange Commission. CryoLife disclaims any obligation or duty to update or
modify these forward-looking statements.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CRYOLIFE, INC.
Date: August 11, 2003 By: /s/ D. Ashley Lee
--------------------------------------
Name: D. Ashley Lee
Title: Vice President, Chief Financial
Officer and Treasurer
3
EXHIBIT INDEX
Exhibit Number Description Page
-------------- ----------- ----
99.1 Transcript of earnings conference call held August 5, 2003 5
4